Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
Microsoft
MSFT
|
+$309M |
| 3 |
ExxonMobil
XOM
|
+$258M |
| 4 |
Johnson & Johnson
JNJ
|
+$221M |
| 5 |
GE Aerospace
GE
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$25.2M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.83% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTT
2251
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $554K | ﹤0.01% |
53,400
+11,900
| +29% | +$128K |
|
2252
Hackett Group
HCKT
$285M
| $551K | ﹤0.01% |
37,792
+12,792
| +51% | +$183K |
|
|
SIOX
2253
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $551K | ﹤0.01% |
6,175
+937
| +18% | +$100K |
|
|
LION
2254
DELISTED
Fidelity Southern Corporation
LION
| $551K | ﹤0.01% |
35,300
+5,200
| +17% | +$85K |
|
2255
American Public Education
APEI
$837M
| $549K | ﹤0.01% |
27,500
+4,700
| +21% | +$82.6K |
|
2256
Quad
QUAD
$502M
| $549K | ﹤0.01% |
43,900
+8,100
| +23% | +$87.6K |
|
2257
NN Inc
NNBR
$301M
| $548K | ﹤0.01% |
41,480
+7,700
| +23% | +$95.4K |
|
2258
First Bancorp
FBNC
$2.7B
| $547K | ﹤0.01% |
30,000
+5,400
| +22% | +$101K |
|
|
CRR
2259
DELISTED
Carbo Ceramics Inc.
CRR
| $546K | ﹤0.01% |
39,650
+6,750
| +21% | +$116K |
|
|
SN
2260
DELISTED
Sanchez Energy Corporation
SN
| $546K | ﹤0.01% |
102,600
+18,300
| +22% | +$70.9K |
|
2261
Perdoceo Education
PRDO
$1.95B
| $544K | ﹤0.01% |
123,200
+18,500
| +18% | +$61.4K |
|
2262
Hawkins
HWKN
$2.71B
| $543K | ﹤0.01% |
31,188
+5,800
| +23% | +$99.4K |
|
|
RLYP
2263
DELISTED
RELYPSA INC COM
RLYP
| $542K | ﹤0.01% |
41,450
+8,050
| +24% | +$137K |
|
2264
1st Source
SRCE
$2.12B
| $541K | ﹤0.01% |
17,730
+4,000
| +29% | +$122K |
|
2265
Great Southern Bancorp
GSBC
$875M
| $540K | ﹤0.01% |
15,100
+3,000
| +25% | +$116K |
|
|
XENT
2266
DELISTED
Intersect ENT, Inc
XENT
| $540K | ﹤0.01% |
29,400
+5,500
| +23% | +$99.6K |
|
2267
Vanda Pharmaceuticals
VNDA
$298M
| $538K | ﹤0.01% |
66,700
+13,100
| +24% | +$108K |
|
|
NORD
2268
DELISTED
Nord Anglia Education, Inc.
NORD
| $538K | ﹤0.01% |
26,621
+10,200
| +62% | +$187K |
|
|
XCRA
2269
DELISTED
Xcerra Corporation
XCRA
| $537K | ﹤0.01% |
85,400
+16,300
| +24% | +$90.8K |
|
|
XNPT
2270
DELISTED
XENOPORT, INC.
XNPT
| $537K | ﹤0.01% |
122,500
+18,200
| +17% | +$83.9K |
|
|
EGRX
2271
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $535K | ﹤0.01% |
13,700
+2,600
| +23% | +$165K |
|
2272
Plug Power
PLUG
$3.1B
| $534K | ﹤0.01% |
270,100
+54,500
| +25% | +$102K |
|
|
GLUU
2273
DELISTED
Glu Mobile Inc.
GLUU
| $533K | ﹤0.01% |
195,700
+49,100
| +33% | +$141K |
|
|
HDP
2274
DELISTED
Hortonworks, Inc.
HDP
| $531K | ﹤0.01% |
48,800
+21,100
| +76% | +$247K |
|
2275
Ribbon Communications
RBBN
$356M
| $529K | ﹤0.01% |
72,774
+13,600
| +23% | +$90.9K |
|
Similar funds
Swiss National Bank's Q1 2016 Portfolio in Review
As of Q1 2016, Swiss National Bank held 2,649 positions worth $54.5B, up 32% from $41.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Swiss National Bank deployed $13.6B of net new capital in Q1 2016, opening 6 new positions and adding to 2,585 existing holdings. Its largest new stake was Ferrari: 823,472 shares worth $32.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Stellantis, an estimated $25.2M trimmed.
- Swiss National Bank's largest Q1 2016 buy was Ferrari: 823,472 shares worth $32.9M.
- Swiss National Bank added most to Apple in Q1 2016, an estimated $411M increase.
- Swiss National Bank's biggest Q1 2016 reduction was Stellantis, cutting an estimated $25.2M.
- Swiss National Bank fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $58.7M.
- Swiss National Bank's ten largest holdings make up 15% of its $54.5B portfolio in Q1 2016.
- Swiss National Bank opened 6 new positions and closed 38 in Q1 2016.
- Swiss National Bank's portfolio value rose 32% quarter-over-quarter to $54.5B.
Based on Swiss National Bank's 13F filing for Q1 2016, filed 4 May 2016.